Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 14Gastrointestinal 13Genitourinary 11Other hematologic neoplasm 9Gynecologic 9Thoracic 6Head & Neck 6CNS 5Plasma cell 4Sarcoma 3Myeloid 3Tumor-Agnostic 2Lymphoid 2Dermatologic 2Other solid neoplasm 1Endocrine 1

Conditions

Digestive System Carcinoma 1

Interventions

pembrolizumab 26Pemetrexed 26Cisplatin 25Nivolumab 22Carboplatin 16Paclitaxel 14Gemcitabine 12Ipilimumab 11tislelizumab 8durvalumab 8Ramucirumab 8Docetaxel 8talazoparib 7Fluorouracil 7Radiotherapy 6Capecitabine 6tremelimumab 5cobimetinib 5atezolizumab 5adavosertib 5Radiosurgery 5Cyclophosphamide 5Bevacizumab 5olaparib 4avelumab 4Temozolomide 4Sunitinib 4Specimen Handling 4Platinum 4PM 01183 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Standard of Care × Other solid neoplasm × Clear all
NCT04596384 2025-08-19

Home Base Telemonitoring in Gastrointestinal, Genitourinary, or Gynecologic Cancer Patients Undergoing Abdominal Surgery

City of Hope Medical Center

Phase NA Active not recruiting
398 enrolled 8 charts
Other solid neoplasm

Digestive System Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡